Balancing evidence and social responsibility when targeting clinical pharmacy services: the example of people with intellectual disabilities

J Simon Bell, Carl M Kirkpatrick, Christopher P Alderman

Research output: Contribution to journalEditorialOtherpeer-review

4 Citations (Scopus)

Abstract

Evidence from systematic reviews and meta-analyses support the provision of pharmacy services to a range of patient groups. This includes patient groups with high burden conditions such as diabetes, asthma, hypertension and hyperlipidaemia. Evidence is an important factor that guides the development and delivery of new clinical pharmacy services. In the context of finite resources, targeting clinical pharmacy services to patient groups with demonstrated benefits is consistent with the principles of evidence-based decision making.
Original languageEnglish
Pages (from-to)549–550
Number of pages2
JournalInternational Journal of Clinical Pharmacy
Volume37
Issue number4
DOIs
Publication statusPublished - 2015

Cite this